The microcarriers market is projected to reach USD 2.9 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 10.7% during the forecast period. Increasing use of single-use bioreactors for bioprocessing, rising investmnet in R&D for developemnt of vaccines and therapeutic protiens, and increasing government funding for cell and gene therapy. • By product, the consumables segment accounted for the largest share of the microcarriers market
The microcarriers market by product is categorized into major consuambles and equipments.Consumables dominated the market in 2020. The large share of this segment can be attributed to rising awareness about advantages of serum-free media over sera/serum-containing media, growing demand for reagents in research applications and new product launches by prominent market players.
Asia Pacific: The fastest-growing region in the microcarriers market.
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the geographical expasnion by pharmaceutcial companies in emerging countries, collaborations and partnerships between government organizations and biopharmaceutical manufacturers and growth of biopharmaceutical industry.
North America: the largest share of the microcarriers market North America accounted for the largest share of the microcarriers market. Factors such as the to recent approvals for biologics by regulatory authorities, strategic collaborations among well-established players in bioprocesising industry and exponential growth of pharmaceutical sector, especially in the US, are the major factors driving the market growth.
Breakdown of primaries The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows: • By Respondent– Supply Side- 70%, Demand Side- 30% • By Designation— Executives- 25%, CXOs, Directors--30%, Managers - 45% • By Region— North America - 40%, Europe - 25%, APAC – 20%, LATAM- 10%, MEA- 5%
The microcarriers market is dominated by a few globally established players such as Thermo Fisher Scientific (US), Sartorius AG (Germany), Danaher Corporation (US), Corning (US), Eppendorf AG (Germany), BD (US), Merck (Germany), ChemoMetec (Denmark), CESCO Bioengineering (Taiwan), HiMedia Laboratories (India), Esco VacciXcell (Singapore), Lonza Group AG (Switzerland), Getinge AB (Sweden), STEMCELL Technologies Inc. (US), Solida Biotech (Germany), Stobbe Pharma (Sweden), Distek, Inc. (US), Celltainer Biotech (Netherlands), G&G Technologies Inc. (US), Tantti (Taiwan), Percell Biolytica (Sweden), PIERRE GUERIN (France), PBS Biotech, Inc. (US), Meissner Filtration Products, Inc. (US), and ABEC, Inc. (US).
Research Coverage: The report segments the microcarriers market based on region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), Consumables (Media (Sera/Serum-based Media, Serum-free Media, Other Media), Reagents, Microcarriers (Collagen-coated Microcarriers, Cationic Microcarriers, Protein-coated Microcarriers, Untreated Microcarriers, Other Microcarriers), Application (Biopharmaceutical Production (Vaccine Production, Therapeutic Protein Production), Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Other Applications), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic and Research Institutes, Cell Banks)
The report also provides a comprehensive review of market drivers, challenges, and opportunities in the microcarriers market
Key Benefits of Buying the Report: The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments.This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies.
The report also helps stakeholders understand the pulse of the microcarriers market and provides them information on key market drivers, challenges, and opportunities.
Our reports have been used by over 10K customers, including:
243 pages •
By Asia Market Information & Development Company
• Apr 2021
China’s demand for Biologics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
The global biologics safety testing market is projected to reach USD 6.2 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 12.4% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the growth in the biologics and biosimilars markets, growing concerns over cell culture contamination,...
The global single-use assemblies market is projected to reach USD 6.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 23.3% during the forecast period. The growth of the single-use assemblies market can primarily be attributed to the major advantages of single-use technologies as compared to traditional stainless-steel assemblies,...
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
The solvent evaporation market was valued at US$ 470.77 million in 2020 and it is projected to reach US$ 821.41 million by 2028; it is expected to grow at a CAGR of 6.7% during 2021–2028. The factors such as increasing expenditure on R&D, growing development of large-molecule biopharmaceuticals, and surging demand for pure samples in...
96 pages •
By Asia Market Information & Development Company
• May 2021
This study focuses on China’s Biopharmaceuticals industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is...
Executive Summary Global Biologics Safety Testing Market was valued at USD 3463.90 Million in the year 2020. Major factors driving the growth of this market are the growth in pharmaceutical and biotechnology industry driven by government support, the positive trend of R&D investment in the life science sector, increasing...
The microcarrier market is majorly driven by factors such as rising demand for cell-based vaccines and therapeutics, the rapid growth of biologics and biosimilar industry, and increasing R&D and availability of funding for cell therapy research. Many of the current biologics in the pipeline are targeting the indications, which are small-molecule...
The global recombinant proteins market is projected to reach USD 1.7billion by 2026 from USD 1.0billion in 2021, at a CAGR of 9.8% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industryacademia collaborations,...
The global biologics CDMO market (henceforth, referred to as the market studied) was valued at USD 9.93 billion in 2020, and it is expected to reach USD 18.90 billion by 2026, registering a CAGR of 11.2% during 2021-2026 (henceforth, referred to as the forecast period).? - The global pharmaceutical industry is growing at an exponential...
Biologics Penetration Rate
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.